| Literature DB >> 32727511 |
Alexander J Terrill1, Katie J Green2, Angelo Salerno3, Paul A Butterworth2.
Abstract
BACKGROUND: Ingrowing toenails are a common and painful condition often requiring surgical management. Practitioners who perform surgery on ingrowing toenails include orthopaedic surgeons, general practitioners, podiatrists and podiatric surgeons. There has been limited investigation into the specific surgical approaches used by Australian podiatric surgeons for ingrowing toenails, or the associated infection rates for these procedures. The aim of this study was to assess the frequency and type of ingrowing toenail surgery performed by podiatric surgeons, and identify risk factors for post-operative infection.Entities:
Keywords: Infection; Ingrowing toenail; Nail surgery; Onychocryptosis; Podiatry
Mesh:
Year: 2020 PMID: 32727511 PMCID: PMC7391500 DOI: 10.1186/s13047-020-00414-y
Source DB: PubMed Journal: J Foot Ankle Res ISSN: 1757-1146 Impact factor: 2.303
Criteria for surgical site infection classification, reproduced from the ACPS Surgical Audit Tool guidelines, based upon the Australian Council on Health Care Standards clinical indicators (version 3.1, 2012)
| Superficial incisional | Deep incisional |
|---|---|
Infection involves only skin and subcutaneous tissue of this incision Occurs within 30 days after the operative procedure Exhibits 1. Purulent discharge (NOT stitch abscess). 2. Organisms isolated from an aseptically collected culture of fluid or tissue. Note: a positive wound swab (in contrast to wound aspirate) without other significant evidence of infection is not adequate for diagnosis of infection. 3. Displays at the site of incision any of the following signs and symptoms of infection: • Pain or tenderness • Localised swelling • Redness or heat the incision is deliberately explored by the Surgeon resulting in a positive wound culture. Note: A culture-negative finding does not meet this criterion unless the patient was on antibiotics immediately prior to diagnosis. 4. Diagnosis or antimicrobial treatment of superficial incisional infection by the operating Surgeon or Registrar. | Infection involves deep soft tissues (e.g. fascial and muscle layers) AND/OR organs/spaces opened or manipulated during an operation Occurs within 30 days after the operative procedure if implant not present OR within 1 year if implant insitu Exhibits either 1 and/or 2: 1. Purulent drainage from deep soft tissue or drain that is placed through a stab wound into the organ/space. 2. Spontaneous dehiscence at the incision site or the wound is deliberately explored by a surgeon with the patient showing evidence of • Fever 38 °C, localised pain or tenderness with culture positive specimen. A culture-negative finding does not meet this criterion unless the patient was on antibiotics immediately prior to the wound being explored and/or the culture being taken; • Organisms isolated from aseptically obtained culture of fluid or tissue obtained from an organ/space; • An abscess or other evidence of infection involving a deep/organ space is found on direct examination, during re-operation, or by histopathologic or radiologic examination; or • Diagnosis of, or antimicrobial treatment of a deep incisional or organ/space surgical site infection by the operating Surgeon or Registrar. |
Demographics of people undergoing procedures with and without ingrowing nails
| No ingrowing toenail | Ingrowing toenail(s) | ||
|---|---|---|---|
| Mean Age (SD) | 52.4 (17.5) | 39.3 (22.8) | < 0.01* ++ |
| Sex – Female (%) | 4539 (77.6%) | 1045 (57.1%) | < 0.01* + |
| ASA 1 (%) | 3642 (62.2%) | 1290 (70.5%) | < 0.01* + |
| Office based surgical Facility (%) | 862 (14.7%) | 875 (47.8%) | < 0.01* + |
| Total Infections | 93 | 77 | |
| Infection Rate (95% CI) | 1.6% (1.3 to 1.9) | 4.2% (3.3 to 5.2) | |
| Infection – Relative Risk | 1 | 2.72 (2.00–3.69) | < 0.01* + |
* Statistically significant at p < 0.05
+ P value calculated using Fisher’s exact test (two-sided)
++ P Value calculated using Independent samples T Test, Equal variances not assumed
ASA 1 = no systemic disease.
Fig. 1Age and sex of patients diagnosed with ingrowing nail(s)
Descriptions of surgical procedures for management of ingrowing toenail [14]
| Item code | Procedure name | Procedure description | Example |
|---|---|---|---|
| 47915 | Wedge Resection | Wedge resection with removal of segment of nail, ungual fold and portion of the nail bed | Winograd matrixectomy |
| 47916 | Partial Resection | Partial resection of nail, with destruction of nail matrix by phenolisation, electrocautery, laser, sodium hydroxide or acid but not including excision of nail bed | Partial nail avulsion with phenolisation |
| 47918 | Radical Excision | Radical excision of nailbed | Terminal syme |
| 47906 | Total Removal | Removal of digital nail of toe | Total nail avulsion |
Risk factors for infection following surgery in patients with ingrowing nails only
| Infections / n | Infection rate (95% CI) | Risk ratio (95% CI) | ||
|---|---|---|---|---|
| < 18 | 11 / 475 | 2.3% (1.2–4.1) | 1 | |
| 18–59 | 29 / 727 | 4.0% (2.7–5.7) | 1.75 (0.87–3.54) | 0.14 |
| ≥ 60 | 25 / 359 | 7.0% (4.6–10.1) | 3.16 (1.53–6.51) | < 0.01 * |
| Male | 32 / 737 | 4.3% (3.0–6.1) | 1 | |
| Female | 33 / 824 | 4.0% (2.8–5.6) | 0.92 (0.56–1.51) | 0.80 |
| 1 | 44 / 1163 | 3.8% (2.8–5.0) | 1 | |
| ≥ 2 | 21 / 398 | 5.3% (3.3–8.0) | 1.42 (0.83–2.41) | 0.19 |
| Hospital/Surgicentre | 22 / 732 | 3.0% (1.9–4.5) | 1 | |
| Office | 43 / 829 | 5.2% (3.8–6.9) | 1.77 (1.05–2.98) | 0.04 * |
| Wedge Resection | 31 / 743 | 4.2% (2.9–5.9) | 1 | |
| Partial Resection | 22 / 578 | 3.8% (2.4–5.7) | 0.91 (0.52–1.59) | 0.78 |
| Radical Excision | 9 / 97 | 9.3% (4.3–16.9) | 2.35 (1.08–5.01) | 0.04 * |
| Total Removal | 2 / 46 | 4.3% (0.5–14.8) | 1.04 (0.24–4.50) | 1.00 |
| Multiple/other procedures | 1 / 97 | 1.0% (0.0–5.6) | 0.24 (0.03–1.77) | 0.16 |
+ P value calculated using Fisher’s exact test (2-sided)
* Statistically significant at p < 0.05
Demographics of patients undergoing procedure according to type of surgical facility
| Hospital/Surgicentre | Office | ||
|---|---|---|---|
| Mean Age (SD) | 32.4 (21.5) | 40.4 (22.7) | < 0.01* ++ |
| Sex – Female (%) | 381 (52.0%) | 443 (53.4%) | 0.61 + |
| ASA 1 (%) | 565 (77.2%) | 598 (72.1%) | 0.02* + |
* Statistically significant at p < 0.05
+ P value calculated using Fisher’s Exact test (two-sided)
++ P Value calculated using Independent samples T Test, Equal variances not assumed
ASA 1 = no systemic disease.
Demographics of patients undergoing procedure according to type of procedure
| Radical excision | Partial, wedge, or total nail resection a | ||
|---|---|---|---|
| Mean Age (SD) | 54.8 (20.8) | 34.6 (22.0) | < 0.01* ++ |
| Sex – Female (%) | 55 (56.7%) | 703 (51.4%) | 0.35 + |
| ASA 1 (%) | 50 (51.5%) | 1047 (76.6%) | < 0.01* + |
| Office Based Facility | 76 (78.4%) | 710 (51.9%) | < 0.01* + |
aOther/Multiple procedures were excluded from this grouping.
* Statistically significant at p < 0.05
+ P value calculated using Fisher’s exact test (two-sided)
++ P Value calculated using Independent samples T Test, Equal variances not assumed
ASA 1 = no systemic disease.
Infection rates depending on procedure and location
| Infection/n | Infection rate (95% CI) | Risk ratio (95% CI) | ||
|---|---|---|---|---|
| Hospital/Surgicentre | 14 / 480 | 2.9% (1.6–4.8) | 1 | |
| Office | 17 / 263 | 6.5% (3.8–10.1) | 2.30 (1.12–4.75) | 0.03* + |
| Hospital/Surgicentre | 6 / 171 | 3.5% (1.3–7.5) | 1 | |
| Office | 16 / 407 | 3.9% (2.3–6.3) | 1.13 (0.43–2.93) | 1.00 + |
+ P value calculated using Fisher’s exact test (two-sided)
* Statistically significant at p < 0.05